Ritocom (Lopinavir + Ritonavir)

Ritocom is a combination antiretroviral medication containing lopinavir and ritonavir, prescribed to manage HIV infection. This FDA/DOH/WHO-recommended. As a potent protease inhibitor, it works by blocking viral enzymes essential for HIV replication, helping to slow disease progression and support immune system recovery.

This fixed-dose combination is typically taken orally as directed by your healthcare provider, with dosing tailored to individual patient needs and treatment history. Consistent adherence is critical for maintaining viral suppression and preventing drug resistance.

Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort, as well as elevated cholesterol and triglyceride levels. Most patients manage these effects well with proper medical supervision and monitoring.

When used alongside other antiretroviral agents as part of a comprehensive HIV treatment regimen, lopinavir/ritonavir can achieve significant viral load reduction and improve long-term health outcomes. Regular laboratory monitoring and open communication with your healthcare team are essential to optimize therapy and address any concerns.

Always consult your doctor or pharmacist regarding proper dosing, potential drug interactions with other medications or supplements, and strategies to enhance tolerability and treatment success.